75 related articles for article (PubMed ID: 23507393)
1. Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain.
Spencer NG; Bridges LR; Elderfield K; Amir K; Austen B; Howe FA
Neuroimage; 2013 Aug; 76():108-15. PubMed ID: 23507393
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.
Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A
J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201
[TBL] [Abstract][Full Text] [Related]
3. Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice.
Bigot C; Vanhoutte G; Verhoye M; Van der Linden A
Neuroimage; 2014 Feb; 87():111-9. PubMed ID: 24188815
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
[TBL] [Abstract][Full Text] [Related]
5. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
7. Can MRI T
Spencer NG; Lovell DP; Elderfield K; Austen B; Howe FA
MAGMA; 2017 Apr; 30(2):153-163. PubMed ID: 27785640
[TBL] [Abstract][Full Text] [Related]
8. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
10. [The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice].
Li MH; Wang PJ; Chen SQ; Zhang W; Gao XL
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):876-9. PubMed ID: 21600112
[TBL] [Abstract][Full Text] [Related]
11. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease.
Thiessen JD; Glazner KA; Nafez S; Schellenberg AE; Buist R; Martin M; Albensi BC
Brain Struct Funct; 2010 Jul; 215(1):29-36. PubMed ID: 20512361
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in mice.
Luo F; Seifert TR; Edalji R; Loebbert RW; Hradil VP; Harlan J; Schmidt M; Nimmrich V; Cox BF; Fox GB
Neuroscience; 2008 Jul; 155(1):263-9. PubMed ID: 18534764
[TBL] [Abstract][Full Text] [Related]
14. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
Falangola MF; Dyakin VV; Lee SP; Bogart A; Babb JS; Duff K; Nixon R; Helpern JA
NMR Biomed; 2007 May; 20(3):343-51. PubMed ID: 17451178
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
16. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
[TBL] [Abstract][Full Text] [Related]
19. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
20. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
